Safety of propranolol for infantile hemangioma in infants less than five weeks corrected age.

Jorie E GattsMarie C RushJennifer F CheckDiane M SamelakThomas Williams McLean

Published in: Pediatric dermatology (2022)

In this cohort of 24 patients with corrected age <5 weeks (CGA <45 weeks), propranolol was safe and effective for the treatment of infantile hemangiomas. Larger, prospective studies are indicated to investigate propranolol in this age group.

Keyphrases

gestational age
case control
smoking cessation